1995
DOI: 10.1099/13500872-141-12-3221
|View full text |Cite
|
Sign up to set email alerts
|

Insertion element IS 1296 in Mycoplasma mycoides subsp. mycoides small colony identifies a European clonal line distinct from African and Australian strains

Abstract: Strains of Mycoplasma mycoides subsp. mycoides small colony (SC) type, the agent of contagious bovine pleuropneumonia (CBPP), were analysed with respect to the polymorphism of distribution of a newly discovered insertion element, lS1296, on the chromosome. Analysis of 64 strains isolated from Europe, Africa and Australia, including four vaccine strains and the type strain PG1, revealed ten different IS patterns, forming two main clusters. The European strains originated from outbreaks of CBPP in different coun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
50
1
1

Year Published

1997
1997
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(56 citation statements)
references
References 18 publications
4
50
1
1
Order By: Relevance
“…These trials had a precise objective: evaluate the protection afforded by a single injection at the minimum dose required by international standards, i.e., 10 7 viable mycoplasmas per dose (14) for T1sr and T1/44 strains by a contact challenge performed three months after the vaccination. These trials were to be performed in three different African locations, Cameroon, Kenya and Namibia, in order to take into account the genetic variability of the MmmSC strains that could be correlated to a modification of the potency of the vaccine (1,17). In addition, a second protocol was designed in Kenya to assess the protection afforded one year after vaccination.…”
Section: Discussionmentioning
confidence: 99%
“…These trials had a precise objective: evaluate the protection afforded by a single injection at the minimum dose required by international standards, i.e., 10 7 viable mycoplasmas per dose (14) for T1sr and T1/44 strains by a contact challenge performed three months after the vaccination. These trials were to be performed in three different African locations, Cameroon, Kenya and Namibia, in order to take into account the genetic variability of the MmmSC strains that could be correlated to a modification of the potency of the vaccine (1,17). In addition, a second protocol was designed in Kenya to assess the protection afforded one year after vaccination.…”
Section: Discussionmentioning
confidence: 99%
“…The evidence of multiple copies of insertion elements present in the MmmSC genome allowed the development of new typing tools based on Southern blot hybridisation. The use of IS1296 as a probe allowed the clear differentiation of recent European strains from those of African origin [7]. The observed difference was explained later on by the identification of an 8.8 kbp deletion in the genome of most MmmSC strains of European origin [43], resulting in a missing IS1296 band.…”
Section: Introductionmentioning
confidence: 99%
“…These reemerging outbreaks in Europe were due to a particular cluster of M. mycoides subsp. mycoides SC strains which were not present on other continents, as observed by IS1296 typing [7]. In this respect, small ruminants have been proposed as possible reservoirs of the pathogen [22,25].…”
Section: Introductionmentioning
confidence: 87%
“…Mycoplasmal cultures were grown in a standard mycoplasma medium [4] to a density of 10 8 -10 9 cells/mL. Crude lysate preparations with GES buffer (5 M guanidium thiocyanate, 100 mM EDTA, 0.5% N-lauroylsarcosine) and DNA extraction were performed as previously described [7].…”
Section: Strains Growth Conditions and Dna Extractionmentioning
confidence: 99%